AK295 (CX295) is a calpain inhibitor that suppresses apoptosis via calpain-dependent pathways; it improves neurological function in rat models of spinal cord injury (SCI) and is used in research on neurodegenerative diseases such as spinal and bulbar muscular atrophy, stroke, Alzheimer's disease, Parkinson's disease, and multiple sclerosis.